These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20442441)

  • 41. Deficient mismatch repair testing in colorectal cancer: more than just screening for Lynch syndrome.
    West NP
    Colorectal Dis; 2019 Jun; 21(6):621-622. PubMed ID: 31152577
    [No Abstract]   [Full Text] [Related]  

  • 42. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.
    Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z
    Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hereditary nonpolyposis colorectal carcinoma: state of the art].
    Holinski-Feder E; Morak M
    Dtsch Med Wochenschr; 2008 Aug; 133(33):1690-5. PubMed ID: 18686212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microsatellite instability and mismatch repair genes in colorectal cancer: useful tools for managing patients and counseling their relatives.
    Douillard JY
    Clin Colorectal Cancer; 2010 Oct; 9(4):193-4. PubMed ID: 20920989
    [No Abstract]   [Full Text] [Related]  

  • 45. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.
    Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ
    Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sebaceous neoplasms and the immunoprofile of mismatch-repair proteins as a screening target for syndromic cases.
    Boennelycke M; Thomsen BM; Holck S
    Pathol Res Pract; 2015 Jan; 211(1):78-82. PubMed ID: 25457183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA mismatch repair and Lynch syndrome.
    Plotz G; Zeuzem S; Raedle J
    J Mol Histol; 2006 Sep; 37(5-7):271-83. PubMed ID: 16821093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain Cancers in Genetic Syndromes.
    Komlodi-Pasztor E; Blakeley JO
    Curr Neurol Neurosci Rep; 2021 Nov; 21(11):64. PubMed ID: 34806136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biallelic PMS2 mutations and a distinctive childhood cancer syndrome.
    Tan TY; Orme LM; Lynch E; Croxford MA; Dow C; Dewan PA; Lipton L
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):254-7. PubMed ID: 18376293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel.
    Abu Freha N; Leibovici Weissman Y; Fich A; Barnes Kedar I; Halpern M; Sztarkier I; Behar DM; Arbib Sneh O; Vilkin A; Baris HN; Gingold R; Lejbkowicz F; Niv Y; Goldberg Y; Levi Z
    Fam Cancer; 2018 Jan; 17(1):79-86. PubMed ID: 28608265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.
    Clay MR; Allison KH; Folkins AK; Longacre TA
    Am J Surg Pathol; 2014 Nov; 38(11):1494-500. PubMed ID: 24921635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.
    Bakry D; Aronson M; Durno C; Rimawi H; Farah R; Alharbi QK; Alharbi M; Shamvil A; Ben-Shachar S; Mistry M; Constantini S; Dvir R; Qaddoumi I; Gallinger S; Lerner-Ellis J; Pollett A; Stephens D; Kelies S; Chao E; Malkin D; Bouffet E; Hawkins C; Tabori U
    Eur J Cancer; 2014 Mar; 50(5):987-96. PubMed ID: 24440087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).
    Leenders EKSM; Westdorp H; Brüggemann RJ; Loeffen J; Kratz C; Burn J; Hoogerbrugge N; Jongmans MCJ
    Eur J Hum Genet; 2018 Oct; 26(10):1417-1423. PubMed ID: 29904176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Why all young bowel cancer patients should be screened for Lynch syndrome.
    Harris M;
    ANZ J Surg; 2008 Jul; 78(7):531-2. PubMed ID: 18593404
    [No Abstract]   [Full Text] [Related]  

  • 55. New genetic test for Lynch syndrome.
    Kerr C
    Lancet Oncol; 2006 Nov; 7(11):892. PubMed ID: 17099981
    [No Abstract]   [Full Text] [Related]  

  • 56. RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.
    Tuccori M; Filion KB; Azoulay L
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711870
    [No Abstract]   [Full Text] [Related]  

  • 57. Lynch syndrome in colorectal cancer patients.
    Giráldez MD; Castellví-Bel S; Balaguer F; Gonzalo V; Ocaña T; Castells A
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):573-83. PubMed ID: 18402524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair-deficiency and Lynch syndrome.
    Maletzki C; Huehns M; Bauer I; Ripperger T; Mork MM; Vilar E; Klöcking S; Zettl H; Prall F; Linnebacher M
    Mol Carcinog; 2017 Jul; 56(7):1753-1764. PubMed ID: 28218421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Small cell carcinoma: arising in Lynch syndrome: a previously undocumented occurrence.
    Oman SA; Ballinger L; Cerilli LA
    Int J Surg Pathol; 2009 Feb; 17(1):46-50. PubMed ID: 18480399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA mismatch repair in prostate cancer.
    Beltran H
    J Clin Oncol; 2013 May; 31(14):1782-4. PubMed ID: 23530097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.